60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) shares, rose in value, with the stock price down by -8.33% to the previous day’s close as strong demand from buyers drove the stock to $1.98.
Actively observing the price movement in the recent trading, the stock is buoying the session at $2.16, falling within a range of $1.91 and $2.12. Referring to stock’s 52-week performance, its high was $35.99, and the low was $1.41. On the whole, SXTP has fluctuated by -16.46% over the past month.
With the market capitalization of 60 Degrees Pharmaceuticals Inc currently standing at about $2.91 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-15.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 1.4M, with a low estimate of 320k and a high estimate of 320k. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 320k.
The stock’s technical analysis shows that the price of SXTP currently trading nearly -20.12% and -23.34% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.99, while the 7-day volatility ratio is showing 3.82% which for the 30-day chart, stands at 7.48%. Furthermore, 60 Degrees Pharmaceuticals Inc (SXTP)’s beta value is 2.89, and its average true range (ATR) is 0.30.
A comparison of 60 Degrees Pharmaceuticals Inc (SXTP) with its peers suggests the former has fared considerably weaker in the market. SXTP showed an intraday change of -8.33% in today’s session so far, and over the past year, it shrunk by -88.08%%.
Data on historical trading for 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) indicates that the trading volumes over the past 10 days have averaged 0.14 and over the past 3 months, they’ve averaged 1.60 million. According to company’s latest data on outstanding shares, there are 1.47 million shares outstanding.
Nearly 6.91% of 60 Degrees Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 2.04% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17898.0 shares as on 2025-05-30, resulting in a short ratio of 0.38. According to the data, the short interest in 60 Degrees Pharmaceuticals Inc (SXTP) stood at 124.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 28622.0. The stock has fallen by -69.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SXTP stock heading into the next quarter.
